Nuclear transcription factor-κB as a target for cancer drug development

Nuclear factor kappa B (NF-κB) is a family of inducible transcription factors found virtually ubiquitously in all cells. Since its discovery by Sen and Baltimore in 1986, much has been discovered about its mechanisms of activation, its target genes, and its function in a variety of human diseases including those related to inflammation, asthma, atherosclerosis, AIDS, septic shock, arthritis, and cancer. Due to its role in a wide variety of diseases, NF-κB has become one of the major targets for drug development. Here, we review our current knowledge of NF-κB, the possible mechanisms of its activation, its potential role in cancer, and various strategies being employed to target the NF-κB signaling pathway for cancer drug development.

[1]  David Baltimore,et al.  Inducibility of κ immunoglobulin enhancer-binding protein NF-κB by a posttranslational mechanism , 1986, Cell.

[2]  P. Herrlich,et al.  UV-induced transcription from the human immunodeficiency virus type 1 (HIV-1) long terminal repeat and UV-induced secretion of an extracellular factor that induces HIV-1 transcription in nonirradiated cells , 1989, Journal of virology.

[3]  P. Baeuerle,et al.  Regulation of tumor necrosis factor alpha transcription in macrophages: involvement of four kappa B-like motifs and of constitutive and inducible forms of NF-kappa B , 1990, Molecular and cellular biology.

[4]  C V Jongeneel,et al.  Kappa B-type enhancers are involved in lipopolysaccharide-mediated transcriptional activation of the tumor necrosis factor alpha gene in primary macrophages , 1990, The Journal of experimental medicine.

[5]  P. Baeuerle,et al.  Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF‐kappa B transcription factor and HIV‐1. , 1991, The EMBO journal.

[6]  R. Chaganti,et al.  B cell lymphoma-associated chromosomal translocation involves candidate oncogene lyt-10, homologous to NF-kappa B p50. , 1991, Cell.

[7]  F. Arenzana‐Seisdedos,et al.  HIV enhancer activity perpetuated by NF-κB induction on infection of monocytes , 1991, Nature.

[8]  R. Chaganti,et al.  B cell lymphoma-associated chromosomal translocation involves candidate oncogene lyt-10, homologous to NF-κB p50 , 1991, Cell.

[9]  J. Whelan,et al.  An NF kappa B-like factor is essential but not sufficient for cytokine induction of endothelial leukocyte adhesion molecule 1 (ELAM-1) gene transcription. , 1991, Nucleic acids research.

[10]  J. D. Thompson,et al.  Alterations at the rel locus in human lymphoma. , 1991, Oncogene.

[11]  K. Busam,et al.  Staphylococcus aureus and derived exotoxins induce nuclear factor kappa B-like activity in murine bone marrow macrophages , 1992, Infection and immunity.

[12]  J. McPherson,et al.  Related subunits of NF-kappa B map to two distinct loci associated with translocations in leukemia, NFKB1 and NFKB2. , 1992, Genomics.

[13]  D. Männel,et al.  Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells , 1992, The Journal of experimental medicine.

[14]  G. Rosen,et al.  Characterization of the promoter for vascular cell adhesion molecule-1 (VCAM-1). , 1992, The Journal of biological chemistry.

[15]  M. Roederer,et al.  Antioxidants inhibit stimulation of HIV transcription. , 1993, AIDS research and human retroviruses.

[16]  L. Cro,et al.  Structural alterations of the NF-kappa B transcription factor lyt-10 in lymphoid malignancies. , 1993, Oncogene.

[17]  R. Dalla‐Favera,et al.  Chromosomal localization of genes encoding the transcription factors, c-rel, NF-kappa Bp50, NF-kappa Bp65, and lyt-10 by fluorescence in situ hybridization. , 1993, Oncogene.

[18]  A. Arnold,et al.  PRAD1/lCyclin D1 proto‐oncogene: Genomic organization, 5′ dna sequence, and sequence of a tumor‐specific rearrangement breakpoint , 1993 .

[19]  A. Baldwin,et al.  Kappa B site-dependent induction of gene expression by diverse inducers of nuclear factor kappa B requires Raf-1. , 1993, The Journal of biological chemistry.

[20]  Lozano,et al.  A dominant negative protein kinase C zeta subspecies blocks NF-kappa B activation , 1993, Molecular and cellular biology.

[21]  B. Vandenbunder,et al.  High levels of c-rel expression are associated with programmed cell death in the developing avian embryo and in bone marrow cells in vitro , 1993, Cell.

[22]  J. Folkman.  Diagnostic and therapeutic applications of angiogenesis research. , 1993, Comptes rendus de l'Academie des sciences. Serie III, Sciences de la vie.

[23]  A. Koong,et al.  Hypoxia Causes the Activation of Nuclear Factor κB through the Phosphorylation of IκBα on Tyrosine Residues , 1994 .

[24]  I. Verma,et al.  Enhanced I kappa B alpha degradation is responsible for constitutive NF-kappa B activity in mature murine B-cell lines , 1994, Molecular and cellular biology.

[25]  S. Ghosh,et al.  Inhibition of NF-kappa B by sodium salicylate and aspirin. , 1994, Science.

[26]  Aseem Kumar,et al.  Double-stranded RNA-dependent protein kinase activates transcription factor NF-kappa B by phosphorylating I kappa B. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[27]  W. Shearer,et al.  Activation of NF-KB and Immunoglobulin Expression in Response to Platelet-Activating Factor in a Human B Cell Line , 1994 .

[28]  J. Johnson,et al.  12-O-tetradecanoylphorbol-13-acetate- and tumor necrosis factor alpha-mediated induction of intercellular adhesion molecule-1 is inhibited by dexamethasone. Functional analysis of the human intercellular adhesion molecular-1 promoter. , 1994, The Journal of biological chemistry.

[29]  M. Rocchi,et al.  Heterogeneous chromosomal aberrations generate 3' truncations of the NFKB2/lyt-10 gene in lymphoid malignancies. , 1994, Blood.

[30]  S. Kato,et al.  Platelet-Activating Factor (PAF) Positively Auto-Regulates the Expression of Human PAF Receptor Transcript 1 (Leukocyte-Type) Through NF-κB , 1994 .

[31]  C. Gélinas,et al.  Rearrangement and altered expression of the NFKB-2 gene in human cutaneous T-lymphoma cells. , 1994, Oncogene.

[32]  V. Castronovo,et al.  The NF-kappa B transcription factor and cancer: high expression of NF-kappa B- and I kappa B-related proteins in tumor cell lines. , 1994, Biochemical pharmacology.

[33]  S. Ohno,et al.  NF-kappa B and Sp1 regulate transcription of the human monocyte chemoattractant protein-1 gene. , 1994, Journal of immunology.

[34]  Tom Maniatis,et al.  The ubiquitinproteasome pathway is required for processing the NF-κB1 precursor protein and the activation of NF-κB , 1994, Cell.

[35]  A. Koong,et al.  Hypoxia causes the activation of nuclear factor kappa B through the phosphorylation of I kappa B alpha on tyrosine residues. , 1994, Cancer research.

[36]  A. Goldberg,et al.  The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B. , 1994, Cell.

[37]  G. Franzoso,et al.  Structure, regulation and function of NF-kappa B. , 1994, Annual review of cell biology.

[38]  E. A. O'neill,et al.  Calcineurin acts in synergy with PMA to inactivate I kappa B/MAD3, an inhibitor of NF‐kappa B. , 1994, The EMBO journal.

[39]  E M Schwarz,et al.  Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation. , 1995, Genes & development.

[40]  B. Aggarwal,et al.  Protein-tyrosine Phosphatase Inhibitors Block Tumor Necrosis Factor-dependent Activation of the Nuclear Transcription Factor NF-B (*) , 1995, The Journal of Biological Chemistry.

[41]  Joseph A. DiDonato,et al.  Immunosuppression by Glucocorticoids: Inhibition of NF-κB Activity Through Induction of IκB Synthesis , 1995, Science.

[42]  A. Strasser,et al.  Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression. , 1995, Genes & development.

[43]  David Baltimore,et al.  Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB , 1995, Nature.

[44]  F. A. La Rosa,et al.  Role of the Rel-family of transcription factors in the regulation of c-myc gene transcription and apoptosis of WEHI 231 murine B-cells. , 1995, Current topics in microbiology and immunology.

[45]  D. Baltimore,et al.  Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B. , 1995, Nature.

[46]  B. Aggarwal,et al.  Activation of transcription factor NF-kappa B is suppressed by curcumin (diferuloylmethane) [corrected]. , 1995, The Journal of biological chemistry.

[47]  T. Torgerson,et al.  Inhibition of Nuclear Translocation of Transcription Factor NF-κB by a Synthetic Peptide Containing a Cell Membrane-permeable Motif and Nuclear Localization Sequence (*) , 1995, The Journal of Biological Chemistry.

[48]  B. Aggarwal,et al.  Activation of Transcription Factor NF-κB Is Suppressed by Curcumin (Diferuloylmethane) (*) , 1995, The Journal of Biological Chemistry.

[49]  V. Castronovo,et al.  Highly-expressed p100/p52 (NFKB2) sequesters other NF-kappa B-related proteins in the cytoplasm of human breast cancer cells. , 1995, Oncogene.

[50]  David Baltimore,et al.  Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune responses , 1995, Cell.

[51]  E. A. O'neill,et al.  The effect of sodium salicylate and aspirin on NF-kappa B. , 1995, Science.

[52]  M. Karin,et al.  Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis. , 1995, Science.

[53]  Y. Kitade,et al.  Inhibition of the DNA‐binding activity of NF‐κB by gold compounds in vitro , 1995 .

[54]  G. Riethmüller,et al.  Fas/Apo-1 activates nuclear factor kappa B and induces interleukin-6 production. , 1995, Journal of inflammation.

[55]  E. A. O'neill,et al.  The Effect of Sodium Salicylate and Aspirin on NF-kappaB , 1995, Science.

[56]  Y. Kitade,et al.  Inhibition of the DNA-binding activity of NF-kappa B by gold compounds in vitro. , 1995, FEBS letters.

[57]  D. Kelleher,et al.  Cellular Proliferation and Activation of NFκB Are Induced by Autocrine Production of Tumor Necrosis Factor α in the Human T Lymphoma Line HuT 78 (*) , 1995, The Journal of Biological Chemistry.

[58]  D. Baltimore,et al.  Constitutive NF-kappa B activation, enhanced granulopoiesis, and neonatal lethality in I kappa B alpha-deficient mice. , 1995, Genes & development.

[59]  F. Bertrand,et al.  Insulin Activates Nuclear Factor κB in Mammalian Cells through a Raf-1-mediated Pathway (*) , 1995, The Journal of Biological Chemistry.

[60]  D. Latchman.  Cell stress genes and neuronal protection , 1995, Neuropathology and applied neurobiology.

[61]  L. Baldini,et al.  Molecular analysis of cutaneous B- and T-cell lymphomas. , 1995, Blood.

[62]  A. Ding,et al.  Activation of NF-kappa B in murine macrophages by taxol. , 1995, Cancer biochemistry biophysics.

[63]  H. Pahl,et al.  Expression of influenza virus hemagglutinin activates transcription factor NF-kappa B , 1995, Journal of virology.

[64]  N. Fausto,et al.  Rapid DNA binding by nuclear factor kappa B in hepatocytes at the start of liver regeneration. , 1995, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[65]  J. Roth,et al.  Altered expression of the p50 subunit of the NF-kappa B transcription factor complex in non-small cell lung carcinoma. , 1995, Oncogene.

[66]  David Baltimore,et al.  An Essential Role for NF-κB in Preventing TNF-α-Induced Cell Death , 1996, Science.

[67]  P. Parker,et al.  Up-Regulation of Protein Kinase C-ε Promotes the Expression of Cytokine-inducible Nitric Oxide Synthase in RAW 264.7 Cells* , 1996, The Journal of Biological Chemistry.

[68]  A. Tarakhovsky,et al.  Immunodeficiency in Protein Kinase Cβ-Deficient Mice , 1996, Science.

[69]  H. W. Sharma,et al.  The NF-kappaB transcription factor in oncogenesis. , 1996, Anticancer research.

[70]  B. Aggarwal,et al.  Capsaicin (8-methyl-N-vanillyl-6-nonenamide) is a potent inhibitor of nuclear transcription factor-kappa B activation by diverse agents. , 1996, Journal of immunology.

[71]  F. Bach,et al.  Glucocorticoid-mediated Repression of NFκB Activity in Endothelial Cells Does Not Involve Induction of IκBα Synthesis* , 1996, The Journal of Biological Chemistry.

[72]  T. H. Wang,et al.  p53, apoptosis and human cancers. , 1996, Journal of the Formosan Medical Association = Taiwan yi zhi.

[73]  Zhaodan Cao,et al.  TRAF6 is a signal transducer for interleukin-1 , 1996, Nature.

[74]  F. Bach,et al.  Glucocorticoid-mediated repression of NFkappaB activity in endothelial cells does not involve induction of IkappaBalpha synthesis. , 1996, The Journal of biological chemistry.

[75]  C. Y. Wang,et al.  TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB. , 1996, Science.

[76]  C. Stewart,et al.  IkappaBalpha deficiency results in a sustained NF-kappaB response and severe widespread dermatitis in mice , 1996, Molecular and cellular biology.

[77]  Hong-Bing Shu,et al.  TRADD–TRAF2 and TRADD–FADD Interactions Define Two Distinct TNF Receptor 1 Signal Transduction Pathways , 1996, Cell.

[78]  Marty W. Mayo,et al.  TNF- and Cancer Therapy-Induced Apoptosis: Potentiation by Inhibition of NF-κB , 1996, Science.

[79]  B. Aggarwal,et al.  Site-specific Tyrosine Phosphorylation of IκBα Negatively Regulates Its Inducible Phosphorylation and Degradation* , 1996, The Journal of Biological Chemistry.

[80]  A. Strasser,et al.  Rel-deficient T cells exhibit defects in production of interleukin 3 and granulocyte-macrophage colony-stimulating factor. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[81]  J. Stark,et al.  Copyright � 1996, American Society for Microbiology Inhibition of Viral Replication Reverses Respiratory Syncytial Virus-Induced NF-�B Activation and Interleukin-8 Gene , 1996 .

[82]  P. Lichter,et al.  Primary mediastinal (thymic) B-cell lymphoma is characterized by gains of chromosomal material including 9p and amplification of the REL gene. , 1996, Blood.

[83]  I. Verma,et al.  Signal-induced degradation of I(kappa)B(alpha): association with NF-kappaB and the PEST sequence in I(kappa)B(alpha) are not required , 1996, Molecular and cellular biology.

[84]  C. Mueller-Dieckmann,et al.  Tyrosine Phosphorylation of IκB-α Activates NF-κB without Proteolytic Degradation of IκB-α , 1996, Cell.

[85]  D. Green,et al.  Suppression of TNF-alpha-induced apoptosis by NF-kappaB. , 1996, Science.

[86]  D. Katz,et al.  Inhibition of NF‐kappaB/Rel induces apoptosis of murine B cells. , 1996, The EMBO journal.

[87]  D. Baltimore,et al.  An essential role for NF-kappaB in preventing TNF-alpha-induced cell death. , 1996, Science.

[88]  B. Aggarwal,et al.  Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-kappa B. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[89]  A. Brasier,et al.  Angiotensinogen gene activation by angiotensin II is mediated by the rel A (nuclear factor-kappaB p65) transcription factor: one mechanism for the renin angiotensin system positive feedback loop in hepatocytes. , 1996, Molecular endocrinology.

[90]  B. Dörken,et al.  High-level nuclear NF-kappa B and Oct-2 is a common feature of cultured Hodgkin/Reed-Sternberg cells. , 1996, Blood.

[91]  D. Goeddel,et al.  I-TRAF is a novel TRAF-interacting protein that regulates TRAF-mediated signal transduction. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[92]  Maria Panico,et al.  Inhibition of NF-κB DNA Binding by Nitric Oxide , 1996 .

[93]  M. Arsura,et al.  TGFβ1 Inhibits NF-κB/Rel Activity Inducing Apoptosis of B Cells: Transcriptional Activation of IκBα , 1996 .

[94]  K. Schulze-Osthoff,et al.  The immunosuppressive fungal metabolite gliotoxin specifically inhibits transcription factor NF-kappaB , 1996, The Journal of experimental medicine.

[95]  D. Baltimore,et al.  B cells from p50/NF-kappa B knockout mice have selective defects in proliferation, differentiation, germ-line CH transcription, and Ig class switching. , 1996, Journal of immunology.

[96]  K. Offit,et al.  REL proto-oncogene is frequently amplified in extranodal diffuse large cell lymphoma , 1996 .

[97]  K. Offit,et al.  REL proto-oncogene is frequently amplified in extranodal diffuse large cell lymphoma. , 1996, Blood.

[98]  M. Arsura,et al.  TGF beta 1 inhibits NF-kappa B/Rel activity inducing apoptosis of B cells: transcriptional activation of I kappa B alpha. , 1996, Immunity.

[99]  S. Gerondakis,et al.  The Rel subunit of NF‐kappaB‐like transcription factors is a positive and negative regulator of macrophage gene expression: distinct roles for Rel in different macrophage populations. , 1996, The EMBO journal.

[100]  H. Takebe,et al.  Enhanced radiosensitivity by inhibition of nuclear factor kappa B activation in human malignant glioma cells. , 1996, International journal of radiation biology.

[101]  M. Boothby,et al.  Perturbation of the T Lymphocyte Lineage In Transgenic Mice Expressing a Constitutive Repressor of Nuclear Factor (NF)-κB , 1997, The Journal of experimental medicine.

[102]  David M. Rothwarf,et al.  A cytokine-responsive IκB kinase that activates the transcription factor NF-κB , 1997, Nature.

[103]  Y. Obata,et al.  NF-κB RelA-deficient Lymphocytes: Normal Development of  T Cells and B Cells, Impaired Production of IgA and IgG1 and Reduced Proliferative Responses , 1997, The Journal of experimental medicine.

[104]  A. Richmond,et al.  Enhanced Degradation of I-κBα Contributes to Endogenous Activation of NF-κB in Hs294T Melanoma Cells , 1997 .

[105]  H. Erdjument-Bromage,et al.  The Transcriptional Activity of NF-κB Is Regulated by the IκB-Associated PKAc Subunit through a Cyclic AMP–Independent Mechanism , 1997, Cell.

[106]  A. Rossi,et al.  Inhibition of nuclear factor kappa B by prostaglandin A1: an effect associated with heat shock transcription factor activation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[107]  Mike Rothe,et al.  IκB Kinase-β: NF-κB Activation and Complex Formation with IκB Kinase-α and NIK , 1997 .

[108]  G. Courtois,et al.  Down-regulation of NF-kappaB activity and NF-kappaB p65 subunit expression by ras and polyoma middle T oncogenes in human colonic Caco-2 cells. , 1997, Oncogene.

[109]  M. C. Hu,et al.  Activation of the Hematopoietic Progenitor Kinase-1 (HPK1)-dependent, Stress-activated c-Jun N-terminal Kinase (JNK) Pathway by Transforming Growth Factor β (TGF-β)-activated Kinase (TAK1), a Kinase Mediator of TGF β Signal Transduction* , 1997, The Journal of Biological Chemistry.

[110]  A. Richmond,et al.  Enhanced degradation of I-kappaB alpha contributes to endogenous activation of NF-kappaB in Hs294T melanoma cells. , 1997, Cancer research.

[111]  Riaz-ul-Haq,et al.  Activation of nuclear factor-kappaB in cultured endothelial cells by increased glucose concentration: prevention by calphostin C. , 1997, Journal of cardiovascular pharmacology.

[112]  A. Lentsch,et al.  In vivo suppression of NF-kappa B and preservation of I kappa B alpha by interleukin-10 and interleukin-13. , 1997, The Journal of clinical investigation.

[113]  A. E. Rogers,et al.  Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer. , 1997, The Journal of clinical investigation.

[114]  W. Liao,et al.  Phosphatidylinositol 3-Kinase in Interleukin 1 Signaling , 1997, The Journal of Biological Chemistry.

[115]  Matthias Mann,et al.  IKK-1 and IKK-2: Cytokine-Activated IκB Kinases Essential for NF-κB Activation , 1997 .

[116]  D. Goeddel,et al.  IkappaB kinase-beta: NF-kappaB activation and complex formation with IkappaB kinase-alpha and NIK. , 1997, Science.

[117]  G. Courtois,et al.  Down-regulation of NF-κB activity and NF-κB p65 subunit expression by ras and polyoma middle T oncogenes in human colonic Caco-2 cells , 1997, Oncogene.

[118]  E. Zandi,et al.  The IκB Kinase Complex (IKK) Contains Two Kinase Subunits, IKKα and IKKβ, Necessary for IκB Phosphorylation and NF-κB Activation , 1997, Cell.

[119]  B. Aggarwal,et al.  Sanguinarine (pseudochelerythrine) is a potent inhibitor of NF-kappaB activation, IkappaBalpha phosphorylation, and degradation. , 1997, The Journal of biological chemistry.

[120]  B. Aggarwal,et al.  Sanguinarine (Pseudochelerythrine) Is a Potent Inhibitor of NF-κB Activation, IκBα Phosphorylation, and Degradation* , 1997, The Journal of Biological Chemistry.

[121]  G. Sledge,et al.  Constitutive activation of NF-kappaB during progression of breast cancer to hormone-independent growth , 1997, Molecular and cellular biology.

[122]  A. Ciechanover,et al.  Inhibition of NF-kappa-B cellular function via specific targeting of the I-kappa-B-ubiquitin ligase. , 1997, The EMBO journal.

[123]  B. Dörken,et al.  Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells. , 1997, The Journal of clinical investigation.

[124]  L. Baldini,et al.  Identification of a tumor-associated mutant form of the NF-κB RelA gene with reduced DNA-binding and transactivating activities , 1997, Oncogene.

[125]  A. Ciechanover,et al.  Inhibition of NF‐κB cellular function via specific targeting of the IκB‐ubiquitin ligase , 1997 .

[126]  M. P. Miano,et al.  Expression of the neoplastic phenotype by human thyroid carcinoma cell lines requires NFκB p65 protein expression , 1997, Oncogene.

[127]  Ge Zhou,et al.  NF-κB-mediated Induction of mdr1b Expression by Insulin in Rat Hepatoma Cells* , 1997, The Journal of Biological Chemistry.

[128]  D. Wallach,et al.  MAP3K-related kinase involved in NF-KB induction by TNF, CD95 and IL-1 , 1997, Nature.

[129]  D. Goeddel,et al.  Tumor necrosis factor (TNF)-mediated kinase cascades: bifurcation of nuclear factor-kappaB and c-jun N-terminal kinase (JNK/SAPK) pathways at TNF receptor-associated factor 2. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[130]  P. Baeuerle,et al.  NF-kappa B as a frequent target for immunosuppressive and anti-inflammatory molecules. , 1997, Advances in immunology.

[131]  C Gélinas,et al.  c-Rel arrests the proliferation of HeLa cells and affects critical regulators of the G1/S-phase transition , 1997, Molecular and cellular biology.

[132]  D. Goeddel,et al.  Identification and Characterization of an IκB Kinase , 1997, Cell.

[133]  A. Palotie,et al.  Genomic Organization of Human and Mouse Genes for Vascular Endothelial Growth Factor C* , 1997, The Journal of Biological Chemistry.

[134]  C. Y. Wang,et al.  Requirement of NF-kappaB activation to suppress p53-independent apoptosis induced by oncogenic Ras. , 1997, Science.

[135]  M. Mayo,et al.  Involvement of Egr-1/RelA Synergy in Distinguishing T Cell Activation from Tumor Necrosis Factor-α–induced NF-κB1 Transcription , 1997, The Journal of experimental medicine.

[136]  D. Brenner,et al.  NFkappaB prevents apoptosis and liver dysfunction during liver regeneration. , 1998, The Journal of clinical investigation.

[137]  S. Ghosh,et al.  Phosphorylation of NF-kappa B p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300. , 1998, Molecular cell.

[138]  J. Cigudosa,et al.  Chromosomal and gene amplification in diffuse large B-cell lymphoma. , 1998, Blood.

[139]  D. Carbone,et al.  Vascular endothelial growth factor inhibits the development of dendritic cells and dramatically affects the differentiation of multiple hematopoietic lineages in vivo. , 1998, Blood.

[140]  B. Aggarwal,et al.  Constitutive activation of NF-kappaB causes resistance to apoptosis in human cutaneous T cell lymphoma HuT-78 cells. Autocrine role of tumor necrosis factor and reactive oxygen intermediates. , 1998, The Journal of biological chemistry.

[141]  T. Kondo,et al.  Glutathione downregulates the phosphorylation of I kappa B: autoloop regulation of the NF-kappa B-mediated expression of NF-kappa B subunits by TNF-alpha in mouse vascular endothelial cells. , 1998, Biochemical and biophysical research communications.

[142]  D. Brenner,et al.  Inhibition of proinflammatory molecule production by adenovirus-mediated expression of a nuclear factor kappaB super-repressor in human intestinal epithelial cells. , 1998, Journal of immunology.

[143]  S. Kim,et al.  Human 4-1BB (CD137) signals are mediated by TRAF2 and activate nuclear factor-kappa B. , 1998, Biochemical and biophysical research communications.

[144]  F. Holsboer,et al.  Induction of NF-κB Activity during Haloperidol-Induced Oxidative Toxicity in Clonal Hippocampal Cells: Suppression of NF-κB and Neuroprotection by Antioxidants , 1998, The Journal of Neuroscience.

[145]  H. Döhner,et al.  Characteristic pattern of chromosomal gains and losses in primary large B-cell lymphomas of the gastrointestinal tract. , 1998, Blood.

[146]  S. Manna,et al.  Ectopic Expression of Hepatitis C Virus Core Protein Differentially Regulates Nuclear Transcription Factors , 1998, Journal of Virology.

[147]  E. Zandi,et al.  IKK-γ is an essential regulatory subunit of the IκB kinase complex , 1998, Nature.

[148]  P. Tofilon,et al.  IkappaBalpha degradation is not a requirement for the X-ray-induced activation of nuclear factor kappaB in normal rat astrocytes and human brain tumour cells. , 1998, International journal of radiation biology.

[149]  K. Sumikawa,et al.  Glutathione Downregulates the Phosphorylation of IκB: Autoloop Regulation of the NF-κB-Mediated Expression of NF-κB Subunits by TNF-α in Mouse Vascular Endothelial Cells , 1998 .

[150]  C. Jongeneel,et al.  Survival-independent function of NF-kappaB/Rel during late stages of thymocyte differentiation. , 1998, Molecular immunology.

[151]  Chou-Chi H. Li,et al.  Association of Cdk2/Cyclin E and NF-κB Complexes at G1/S Phase , 1998 .

[152]  R. Freeman,et al.  Nerve Growth Factor-Dependent Activation of NF-κB Contributes to Survival of Sympathetic Neurons , 1998, The Journal of Neuroscience.

[153]  L. Ehrlich,et al.  IL-10 down-regulates human microglial IL-8 by inhibition of NF-kappaB activation. , 1998, Neuroreport.

[154]  C. N. Coleman,et al.  Combined antitumor effect of radiation and ibuprofen in human prostate carcinoma cells. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[155]  C. Snapper,et al.  Nuclear Factor (NF)-κB2 (p100/p52) Is Required for Normal Splenic Microarchitecture and B Cell–mediated Immune Responses , 1998, The Journal of experimental medicine.

[156]  A. Leonardi,et al.  Mice Deficient in Nuclear Factor (NF)-κB/p52 Present with Defects in Humoral Responses, Germinal Center Reactions, and Splenic Microarchitecture , 1998, The Journal of experimental medicine.

[157]  E. Muñoz-Elías,et al.  Vasoactive Intestinal Peptide and Pituitary Adenylate Cyclase-activating Polypeptide Inhibit Tumor Necrosis Factor α Transcriptional Activation by Regulating Nuclear Factor-kB and cAMP Response Element-binding Protein/c-Jun* , 1998, The Journal of Biological Chemistry.

[158]  A. Barchowsky,et al.  Inhibition of NF-kappa B binding to DNA by chromium, cadmium, mercury, zinc, and arsenite in vitro: evidence of a thiol mechanism. , 1998, Archives of biochemistry and biophysics.

[159]  D. Green,et al.  DNA damaging agents induce expression of Fas ligand and subsequent apoptosis in T lymphocytes via the activation of NF-kappa B and AP-1. , 1998, Molecular cell.

[160]  R. Hay,et al.  Defective IkappaBalpha in Hodgkin cell lines with constitutively active NF-kappaB. , 1998, Oncogene.

[161]  M. Neurath,et al.  The yopJ locus is required for Yersinia‐mediated inhibition of NF‐κB activation and cytokine expression: YopJ contains a eukaryotic SH2‐like domain that is essential for its repressive activity , 1998, Molecular microbiology.

[162]  Howard Hughes.  Lactacystin, Proteasome Function, and Cell Fate* , 1998, The Journal of Biological Chemistry.

[163]  E. Jimi,et al.  Activation of NF-κB Is Involved in the Survival of Osteoclasts Promoted by Interleukin-1* , 1998, The Journal of Biological Chemistry.

[164]  K. Harano,et al.  An allosteric drug, o,o'-bismyristoyl thiamine disulfide, suppresses HIV-1 replication through prevention of nuclear translocation of both HIV-1 Tat and NF-kappa B. , 1998, Biochemical and biophysical research communications.

[165]  S. Manna,et al.  IL-13 suppresses TNF-induced activation of nuclear factor-kappa B, activation protein-1, and apoptosis. , 1998, Journal of immunology.

[166]  D. Carbone,et al.  Vascular endothelial growth factor affects dendritic cell maturation through the inhibition of nuclear factor-kappa B activation in hemopoietic progenitor cells. , 1998, Journal of immunology.

[167]  M. Shichiri,et al.  NO Inhibits Cytokine-Induced iNOS Expression and NF-κB Activation by Interfering With Phosphorylation and Degradation of IκB-α , 1998 .

[168]  W. El-Deiry,et al.  p53-mediated repression of nuclear factor-kappaB RelA via the transcriptional integrator p300. , 1998, Cancer research.

[169]  J. Troppmair,et al.  Activation of NF-κB by oncogenic Raf in HEK 293 cells occurs through autocrine recruitment of the stress kinase cascade , 1998, Oncogene.

[170]  D. Brenner,et al.  Mediation by NF-κB of cytokine induced expression of intercellular adhesion molecule 1 (ICAM-1) in an intestinal epithelial cell line, a process blocked by proteasome inhibitors , 1998, Gut.

[171]  M. Shichiri,et al.  NO inhibits cytokine-induced iNOS expression and NF-kappaB activation by interfering with phosphorylation and degradation of IkappaB-alpha. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[172]  Jian-Dong Li,et al.  Activation of NF-kappaB via a Src-dependent Ras-MAPK-pp90rsk pathway is required for Pseudomonas aeruginosa-induced mucin overproduction in epithelial cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[173]  Zhaodan Cao,et al.  NF-κB-inducing kinase activates IKK-α by phosphorylation of Ser-176 , 1998 .

[174]  S. Paul,et al.  The NF-kappaB/Rel family of proteins mediates Abeta-induced neurotoxicity and glial activation. , 1998, Brain research. Molecular brain research.

[175]  A. Vollmar,et al.  The guanylate cyclase–coupled natriuretic peptide receptor: A new target for prevention of cold ischemia–reperfusion damage of the rat liver , 1998, Hepatology.

[176]  B. Binder,et al.  Cytokine induced expression of porcine inhibitor of apoptosis protein (iap) family member is regulated by NF-kappa B. , 1998, Biochemical and biophysical research communications.

[177]  A. Strasser,et al.  B Lymphocytes Differentially Use the Rel and Nuclear Factor κB1 (NF-κB1) Transcription Factors to Regulate Cell Cycle Progression and Apoptosis in Quiescent and Mitogen-activated Cells , 1998, The Journal of experimental medicine.

[178]  S. Paul,et al.  The NF-κB/Rel family of proteins mediates Aβ-induced neurotoxicity and glial activation , 1998 .

[179]  R. Hotchkiss,et al.  Nitric oxide inhibits stress-induced endothelial cell apoptosis. , 1998, Critical care medicine.

[180]  S. Gerondakis,et al.  The regulation and roles of Rel/NF-kappa B transcription factors during lymphocyte activation. , 1998, Current opinion in immunology.

[181]  S. Manna,et al.  Interleukin-4 Down-regulates Both Forms of Tumor Necrosis Factor Receptor and Receptor-mediated Apoptosis, NF-κB, AP-1, and c-Jun N-Terminal Kinase , 1998, The Journal of Biological Chemistry.

[182]  R. Hay,et al.  Defective IκBα in Hodgkin cell lines with constitutively active NF-κB , 1998, Oncogene.

[183]  Ebrahim Zandi,et al.  Direct Phosphorylation of IκB by IKKα and IKKβ: Discrimination Between Free and NF-κB-Bound Substrate , 1998 .

[184]  M. Merville,et al.  Stable inhibition of nuclear factor kappaB in cancer cells does not increase sensitivity to cytotoxic drugs. , 1999, Cancer research.

[185]  T. Okamoto,et al.  Identification of a Novel Inhibitor of Nuclear Factor-κB, RelA-associated Inhibitor* , 1999, The Journal of Biological Chemistry.

[186]  T. Maniatis,et al.  A ubiquitin ligase complex essential for the NF-kappaB, Wnt/Wingless, and Hedgehog signaling pathways. , 1999, Genes & development.

[187]  L. Pfeffer,et al.  NF-κB activation by tumour necrosis factor requires the Akt serine–threonine kinase , 1999, Nature.

[188]  C. Jongeneel,et al.  Efficient adenoviral transfer of NF‐κB inhibitor sensitizes melanoma to tumor necrosis factor‐mediated apoptosis , 1999, International journal of cancer.

[189]  G. Ghosh,et al.  Regulation of DNA binding by Rel/NF-κB transcription factors: structural views , 1999, Oncogene.

[190]  S. Akira,et al.  Limb and skin abnormalities in mice lacking IKKalpha. , 1999, Science.

[191]  H. Kato,et al.  NF-κB subunit p65 binds to 53BP2 and inhibits cell death induced by 53BP2 , 1999, Oncogene.

[192]  T. Deerinck,et al.  Abnormal Morphogenesis But Intact IKK Activation in Mice Lacking the IKKα Subunit of IκB Kinase , 1999 .

[193]  D. Brenner,et al.  IkappaBalpha gene transfer is cytotoxic to squamous-cell lung cancer cells and sensitizes them to tumor necrosis factor-alpha-mediated cell death. , 1999, American journal of respiratory cell and molecular biology.

[194]  M. Diaz-Meco,et al.  The interaction of p62 with RIP links the atypical PKCs to NF‐κB activation , 1999, The EMBO journal.

[195]  A. Manning,et al.  NF-κB as a primary regulator of the stress response , 1999, Oncogene.

[196]  C. Justicia,et al.  Activation of nuclear factor-κB in the rat brain after transient focal ischemia , 1999 .

[197]  Xianglin Shi,et al.  Vanadate Induction of NF-κB Involves IκB Kinase β and SAPK/ERK Kinase 1 in Macrophages* , 1999, The Journal of Biological Chemistry.

[198]  A. Farr,et al.  Oxidative Stress Induces NF-κB Nuclear Translocation Without Degradation of IκBα , 1999 .

[199]  Michael Karin,et al.  Is NF‐κB the sensor of oxidative stress? , 1999 .

[200]  T. Deerinck,et al.  The IKKβ Subunit of IκB Kinase (IKK) is Essential for Nuclear Factor κB Activation and Prevention of Apoptosis , 1999, The Journal of experimental medicine.

[201]  U. Engelmann,et al.  Immunolocalization of inducible and constitutive nitric oxide synthases in human bladder cancer. , 1999, Urology.

[202]  W. Erl,et al.  Nuclear factor-κB regulates induction of apoptosis and inhibitor of apoptosis protein-1 expression in vascular smooth muscle cells , 1999 .

[203]  B. Rayet,et al.  Aberrant rel/nfkb genes and activity in human cancer , 1999, Oncogene.

[204]  D. Baltimore,et al.  NF‐κB activation by a signaling complex containing TRAF2, TANK and TBK1, a novel IKK‐related kinase , 1999, The EMBO journal.

[205]  C. Van Waes,et al.  Constitutive activation of transcription factors NF‐κB, AP‐1, and NF‐IL6 in human head and neck squamous cell carcinoma cell lines that express pro‐inflammatory and pro‐angiogenic cytokines , 1999, Molecular carcinogenesis.

[206]  M. Karin,et al.  Is NF-kappaB the sensor of oxidative stress? , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[207]  F. Vittimberga,et al.  Ubiquitin-proteasome inhibition enhances apoptosis of human pancreatic cancer cells. , 1999, Surgery.

[208]  W. Erl,et al.  Nuclear factor-kappa B regulates induction of apoptosis and inhibitor of apoptosis protein-1 expression in vascular smooth muscle cells. , 1999, Circulation research.

[209]  Douglas B. Evans,et al.  Overexpression of urokinase-type plasminogen activator in pancreatic adenocarcinoma is regulated by constitutively activated RelA , 1999, Oncogene.

[210]  N. Perkins,et al.  Transcriptional cross talk between NF-kappaB and p53. , 1999, Molecular and cellular biology.

[211]  H. Kato,et al.  NF-kappaB subunit p65 binds to 53BP2 and inhibits cell death induced by 53BP2. , 1999, Oncogene.

[212]  F. Uckun,et al.  Innovative treatment programs against cancer: II. nuclear factor-κB (NF-κB) as a molecular target , 1999 .

[213]  P. Elliott,et al.  Inhibition of NF-kappa B activation in vitro and in vivo: role of 26S proteasome. , 1999, Methods in enzymology.

[214]  S. Akira,et al.  IKK-i, a novel lipopolysaccharide-inducible kinase that is related to IkappaB kinases. , 1999, International immunology.

[215]  N. Perkins,et al.  Transcriptional Cross Talk between NF-κB and p53 , 1999, Molecular and Cellular Biology.

[216]  J. Liao,et al.  Assessing induction of I kappa B by nitric oxide. , 1999, Methods in enzymology.

[217]  L. Johnston,et al.  TPL-2 kinase regulates the proteolysis of the NF-κB-inhibitory protein NF-κB1 p105 , 1999, Nature.

[218]  B. Kahn-Perlès,et al.  Physical interaction of the bHLH LYL1 protein and NF-κB1 p105 , 1999, Oncogene.

[219]  M. Diaz-Meco,et al.  Inactivation of the Inhibitory κB Protein Kinase/Nuclear Factor κB Pathway by Par-4 Expression Potentiates Tumor Necrosis Factor α-induced Apoptosis* , 1999, The Journal of Biological Chemistry.

[220]  S. Gerondakis,et al.  Rel-dependent induction of A1 transcription is required to protect B cells from antigen receptor ligation-induced apoptosis. , 1999, Genes & development.

[221]  K. Vousden,et al.  E2F-1 potentiates cell death by blocking antiapoptotic signaling pathways. , 1999, Molecular cell.

[222]  J. Liao,et al.  Assessing induction of I?B by nitric oxide , 1999 .

[223]  Claus Scheidereit,et al.  NF-κB Function in Growth Control: Regulation of Cyclin D1 Expression and G0/G1-to-S-Phase Transition , 1999, Molecular and Cellular Biology.

[224]  B. Dörken,et al.  Molecular mechanisms of constitutive NF-κB/Rel activation in Hodgkin/Reed-Sternberg cells , 1999, Oncogene.

[225]  M. Tomonaga,et al.  Expression of human inducible nitric oxide synthase gene in T-cell lines infected with human T-cell leukemia virus type-I and primary adult T-cell leukemia cells. , 1999, Blood.

[226]  M. Ueffing,et al.  Hydrogen peroxide-induced apoptosis is CD95-independent, requires the release of mitochondria-derived reactive oxygen species and the activation of NF-kappaB. , 1999, Oncogene.

[227]  B. Kahn-Perlès,et al.  Physical interaction of the bHLH LYL1 protein and NF-kappaB1 p105. , 1999, Oncogene.

[228]  D. Goeddel,et al.  Embryonic Lethality, Liver Degeneration, and Impaired NF-κB Activation in IKK-β-Deficient Mice , 1999 .

[229]  T. Ito,et al.  Superoxide mediates cigarette smoke-induced infiltration of neutrophils into the airways through nuclear factor-kappaB activation and IL-8 mRNA expression in guinea pigs in vivo. , 1999, American journal of respiratory cell and molecular biology.

[230]  M. Diaz,et al.  Role of NF-kappaB in the apoptotic-resistant phenotype of keratinocytes. , 1999, The Journal of biological chemistry.

[231]  M. Ueffing,et al.  Hydrogen peroxide-induced apoptosis is CD95-independent, requires the release of mitochondria-derived reactive oxygen species and the activation of NF-κB , 1999, Oncogene.

[232]  A. Miyajima,et al.  An essential role for nuclear factor kappa B in preventing TNF-alpha-induced cell death in prostate cancer cells. , 1999, The Journal of urology.

[233]  Chris Albanese,et al.  NF-κB Controls Cell Growth and Differentiation through Transcriptional Regulation of Cyclin D1 , 1999, Molecular and Cellular Biology.

[234]  Markus Schwaninger,et al.  NF-κB is activated and promotes cell death in focal cerebral ischemia , 1999, Nature Medicine.

[235]  C. Haslett,et al.  NF-κB Activation Is a Critical Regulator of Human Granulocyte Apoptosis in Vitro* , 1999, The Journal of Biological Chemistry.

[236]  Yukio Nakamura,et al.  Genetic approaches in mice to understand Rel/NF-κB and IκB function: transgenics and knockouts , 1999, Oncogene.

[237]  Douglas B. Evans,et al.  The Nuclear Factor-κB RelA Transcription Factor Is Constitutively Activated in Human Pancreatic Adenocarcinoma Cells , 1999 .

[238]  R. Hay,et al.  Mutations in the IkBa gene in Hodgkin's disease suggest a tumour suppressor role for IkappaBalpha. , 1999, Oncogene.

[239]  M. C. Hu,et al.  Hematopoietic progenitor kinase-1 (HPK1) stress response signaling pathway activates IκB kinases (IKK-α/β) and IKK-β is a developmentally regulated protein kinase , 1999, Oncogene.

[240]  T. Gilmore,et al.  Diverse agents act at multiple levels to inhibit the Rel/NF-κB signal transduction pathway , 1999, Oncogene.

[241]  D. Brenner,et al.  I κ B α Gene Transfer Is Cytotoxic to Squamous-Cell Lung Cancer Cells and Sensitizes Them to Tumor Necrosis Factor- α –Mediated Cell Death , 1999 .

[242]  H. Pahl.  Activators and target genes of Rel/NF-κB transcription factors , 1999, Oncogene.

[243]  C. Van Waes,et al.  The host environment promotes the constitutive activation of nuclear factor-kappaB and proinflammatory cytokine expression during metastatic tumor progression of murine squamous cell carcinoma. , 1999, Cancer research.

[244]  C. N. Coleman,et al.  Constitutive activation of IκB kinase α and NF-κB in prostate cancer cells is inhibited by ibuprofen , 1999, Oncogene.

[245]  B. Brüne,et al.  Superoxide attenuates macrophage apoptosis by NF-kappa B and AP-1 activation that promotes cyclooxygenase-2 expression. , 1999, Journal of immunology.

[246]  R. Kao,et al.  Early activation of transcription factor NF-κB during ischemia in perfused rat heart. , 1999, American journal of physiology. Heart and circulatory physiology.

[247]  B. Barlogie,et al.  Role of NF-kappaB in the rescue of multiple myeloma cells from glucocorticoid-induced apoptosis by bcl-2. , 1999, Blood.

[248]  C. N. Coleman,et al.  Constitutive activation of IkappaB kinase alpha and NF-kappaB in prostate cancer cells is inhibited by ibuprofen. , 1999, Oncogene.

[249]  N. Shimizu,et al.  Induction of apoptosis of cytokine-producing bladder cancer cells by adenovirus-mediated IkappaBalpha overexpression. , 1999, Human gene therapy.

[250]  A. Martin-Villalba,et al.  NF-kappaB is activated and promotes cell death in focal cerebral ischemia. , 1999, Nature medicine.

[251]  J. Cusack,et al.  Control of inducible chemoresistance: Enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-κB , 1999, Nature Medicine.

[252]  Marty W. Mayo,et al.  NF-κB Induces Expression of the Bcl-2 Homologue A1/Bfl-1 To Preferentially Suppress Chemotherapy-Induced Apoptosis , 1999, Molecular and Cellular Biology.

[253]  T. Chase,et al.  Nuclear Factor κB Nuclear Translocation Upregulates c-Myc and p53 Expression during NMDA Receptor-Mediated Apoptosis in Rat Striatum , 1999, The Journal of Neuroscience.

[254]  G. Stark,et al.  IRAK-M Is a Novel Member of the Pelle/Interleukin-1 Receptor-associated Kinase (IRAK) Family* , 1999, The Journal of Biological Chemistry.

[255]  L. Owen-Schaub,et al.  Activation-Dependent Transcriptional Regulation of the Human fas Promoter Requires NF-κB p50-p65 Recruitment , 1999, Molecular and Cellular Biology.

[256]  Quan Zhao,et al.  Mitogen-activated Protein Kinase/ERK Kinase Kinases 2 and 3 Activate Nuclear Factor-κB through IκB Kinase-α and IκB Kinase-β* , 1999, The Journal of Biological Chemistry.

[257]  M. Diaz,et al.  Role of NF-κB in the Apoptotic-resistant Phenotype of Keratinocytes* , 1999, The Journal of Biological Chemistry.

[258]  Inder M. Verma,et al.  Severe Liver Degeneration in Mice Lacking the IκB Kinase 2 Gene , 1999 .

[259]  H. Pahl,et al.  Activators and target genes of Rel/NF-kappaB transcription factors. , 1999, Oncogene.

[260]  R. Hay,et al.  Mutations in the IkBa gene in Hodgkin's disease suggest a tumour suppressor role for IκBα , 1999, Oncogene.

[261]  J. Abbruzzese,et al.  The nuclear factor-kappa B RelA transcription factor is constitutively activated in human pancreatic adenocarcinoma cells. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[262]  M. Karin.  How NF-κB is activated: the role of the IκB kinase (IKK) complex , 1999, Oncogene.

[263]  Ching-Chow Chen,et al.  TNF-α-Induced Cyclooxygenase-2 Expression in Human Lung Epithelial Cells: Involvement of the Phospholipase C-γ2, Protein Kinase C-α, Tyrosine Kinase, NF-κB-Inducing Kinase, and I-κB Kinase 1/2 Pathway1 , 2000, The Journal of Immunology.

[264]  S. Akira,et al.  NF‐κB activation through IKK‐i‐dependent I‐TRAF/TANK phosphorylation , 2000, Genes to cells : devoted to molecular & cellular mechanisms.

[265]  T. Maniatis,et al.  IKKε is part of a novel PMA-inducible IkappaB kinase complex. Molecular Cell 5:513-522 , 2000 .

[266]  C. Scheidereit,et al.  Transcription factor NF-κB is constitutively activated in acute lymphoblastic leukemia cells , 2000, Leukemia.

[267]  S. Thorgeirsson,et al.  Role of the IkappaB kinase complex in oncogenic Ras- and Raf-mediated transformation of rat liver epithelial cells. , 2000, Molecular and cellular biology.

[268]  X. Sun,et al.  p300/CBP-dependent and -independent transcriptional interference between NF-kappaB RelA and p53. , 2000, Biochemical and biophysical research communications.

[269]  M. Toyota,et al.  Aberrant methylation of the Cyclooxygenase 2 CpG island in colorectal tumors. , 2000, Cancer research.

[270]  N. K. Sah,et al.  Protein Tyrosine Kinase p56 lck Is Required for Ceramide-induced but Not Tumor Necrosis Factor-induced Activation of NF-κB, AP-1, JNK, and Apoptosis* , 2000, The Journal of Biological Chemistry.

[271]  Y. L. Li,et al.  Effects of antisense IRAK-2 oligonucleotides on PGI2 release induced by IL-1 and TNF. , 2000, Acta pharmacologica Sinica.

[272]  Klaus Rajewsky,et al.  NEMO/IKKγ-Deficient Mice Model Incontinentia Pigmenti , 2000 .

[273]  K. Vousden,et al.  Role of NF-kappaB in p53-mediated programmed cell death. , 2000, Nature.

[274]  C. Harris,et al.  Human mesothelioma samples overexpress both cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (NOS2): in vitro antiproliferative effects of a COX-2 inhibitor. , 2000, Cancer research.

[275]  M. Karin,et al.  NAK is an IκB kinase-activating kinase , 2000, Nature.

[276]  W. Khan,et al.  Bruton's Tyrosine Kinase Is Required for Activation of Iκb Kinase and Nuclear Factor κb in Response to B Cell Receptor Engagement , 2000, The Journal of experimental medicine.

[277]  S. Ghosh,et al.  Selective inhibition of NF-κB activation by a peptide that blocks the interaction of NEMO with the IκB kinase complex , 2000 .

[278]  S. Thorgeirsson,et al.  Role of the IκB Kinase Complex in Oncogenic Ras- and Raf-Mediated Transformation of Rat Liver Epithelial Cells , 2000, Molecular and Cellular Biology.

[279]  M. Mattson,et al.  Pro‐apoptotic action of PAR‐4 involves inhibition of NF‐κB activity and suppression of BCL‐2 expression , 2000, Journal of neuroscience research.

[280]  N. Perkins,et al.  Inhibition of the RelA(p65) NF-kappaB subunit by Egr-1. , 2000, The Journal of biological chemistry.

[281]  A. Vertegaal.  Protein kinase C-$alpha; is an upstream activator of the I$kappa;B kinase complex in the TPA signal transduction pathway to NF-$kappa;B in U2OS cells , 2000 .

[282]  W. Greene,et al.  Protein Kinase C-θ Participates in NF-κB Activation Induced by CD3-CD28 Costimulation through Selective Activation of IκB Kinase β , 2000, Molecular and Cellular Biology.

[283]  T. Mak,et al.  Deficiency of T2K leads to apoptotic liver degeneration and impaired NF‐κB‐dependent gene transcription , 2000, The EMBO journal.

[284]  N. Perkins,et al.  Inhibition of the RelA(p65) NF-κB Subunit by Egr-1* , 2000, The Journal of Biological Chemistry.

[285]  T. Hofmann,et al.  Mixed-Lineage Kinase 3 Delivers CD3/CD28-Derived Signals into the IκB Kinase Complex , 2000, Molecular and Cellular Biology.

[286]  J. Frost,et al.  Stimulation of NFκB Activity by Multiple Signaling Pathways Requires PAK1* , 2000, The Journal of Biological Chemistry.

[287]  T. Maniatis,et al.  IKKε Is Part of a Novel PMA-Inducible IκB Kinase Complex , 2000 .

[288]  F. D’Acquisto,et al.  Local administration of transcription factor decoy oligonucleotides to nuclear factor-κB prevents carrageenin-induced inflammation in rat hind paw , 2000, Gene Therapy.

[289]  K. Vousden,et al.  Role of NF-κB in p53-mediated programmed cell death , 2000, Nature.

[290]  M. Torii,et al.  Effects of roxithromycin on tumor necrosis factor-alpha-induced vascular endothelial growth factor expression in human periodontal ligament cells in culture. , 2000, Journal of periodontology.

[291]  J. Pober,et al.  Selective inhibition of NF-kappaB activation by a peptide that blocks the interaction of NEMO with the IkappaB kinase complex. , 2000, Science.

[292]  H. Saji,et al.  Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[293]  I. Nishimoto,et al.  Prognostic Significance of the Combined Expression of Matrix Metalloproteinase-9, Urokinase Type Plasminogen Activator and its Receptor in Breast Cancer as Measured by Northern Blot Analysis , 2001, The International journal of biological markers.

[294]  A. Kalgutkar,et al.  Discovery and design of selective cyclooxygenase-2 inhibitors as non-ulcerogenic, anti-inflammatory drugs with potential utility as anti-cancer agents. , 2001, Current drug targets.

[295]  M. Karin,et al.  IKKβ Is Essential for Protecting T Cells from TNFα-Induced Apoptosis , 2001 .

[296]  V. Rangnekar,et al.  Par-4 drives trafficking and activation of Fas and Fasl to induce prostate cancer cell apoptosis and tumor regression. , 2001, Cancer research.

[297]  P. Elliott,et al.  Enhancement of radiosensitivity by proteasome inhibition: implications for a role of NF-kappaB. , 2001, International journal of radiation oncology, biology, physics.

[298]  T. Mak,et al.  Bimp1, a MAGUK Family Member Linking Protein Kinase C Activation to Bcl10-mediated NF-κB Induction* , 2001, The Journal of Biological Chemistry.

[299]  J. Clohisy,et al.  TAT Fusion Proteins Containing Tyrosine 42-deleted IκBα Arrest Osteoclastogenesis* , 2001, The Journal of Biological Chemistry.

[300]  F. Balkwill,et al.  Epithelial cancer cell migration: a role for chemokine receptors? , 2001, Cancer research.

[301]  Stuart A. Lipton,et al.  Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-κB signalling cascades , 2001, Nature.

[302]  B. Schraven,et al.  Complex Formation and Cooperation of Protein Kinase Cθ and Akt1/Protein Kinase Bα in the NF-κB Transactivation Cascade in Jurkat T Cells* , 2001, The Journal of Biological Chemistry.

[303]  R. Strieter.  Chemokines: Not just leukocyte chemoattractants in the promotion of cancer , 2001, Nature Immunology.

[304]  M. Hitt,et al.  Combined CXC chemokine and interleukin-12 gene transfer enhances antitumor immunity , 2001, Gene Therapy.

[305]  W. Greene,et al.  Duration of nuclear NF-kappaB action regulated by reversible acetylation. , 2001, Science.

[306]  W. Liao,et al.  The essential role of MEKK3 in TNF-induced NF-κB activation , 2001, Nature Immunology.

[307]  U. Mazurek,et al.  [Vascular endothelial growth factor (VEGF) and its role in neoplastic processes]. , 2001, Postepy higieny i medycyny doswiadczalnej.

[308]  T. Gilmore,et al.  Malignant transformation of primary chicken spleen cells by human transcription factor c-Rel , 2001, Oncogene.

[309]  Michael Karin,et al.  Activation by IKKα of a Second, Evolutionary Conserved, NF-κB Signaling Pathway , 2001, Science.

[310]  P. Elliott,et al.  Enhanced chemosensitivity to CPT-11 with proteasome inhibitor PS-341: implications for systemic nuclear factor-kappaB inhibition. , 2001, Cancer research.

[311]  T. Ichikura,et al.  Significant correlation between expression of interleukin‐1α and liver metastasis in gastric carcinoma , 2001, Cancer.

[312]  I. Vancurova,et al.  NF-kappaB Activation in TNFalpha-Stimulated Neutrophils is Mediated by Protein Kinase C-delta: Correlation to Nuclear I-kappaB-alpha , 2001 .

[313]  L. Marnett,et al.  IκB Kinase, a Molecular Target for Inhibition by 4-Hydroxy-2-nonenal* , 2001, The Journal of Biological Chemistry.

[314]  T. Muta,et al.  A Novel IκB Protein, IκB-ζ, Induced by Proinflammatory Stimuli, Negatively Regulates Nuclear Factor-κB in the Nuclei* , 2001, The Journal of Biological Chemistry.

[315]  L. Marnett,et al.  IkappaB kinase, a molecular target for inhibition by 4-hydroxy-2-nonenal. , 2001, The Journal of biological chemistry.

[316]  R. Fridman,et al.  Differential regulation of matrix metalloproteinase‐9, tissue inhibitor of metalloproteinase‐1 (TIMP‐1) and TIMP‐2 expression in co‐cultures of prostate cancer and stromal cells , 2001, International journal of cancer.

[317]  Eric Verdin,et al.  Duration of Nuclear NF-κB Action Regulated by Reversible Acetylation , 2001, Science.

[318]  G. W. Peet,et al.  Novel NEMO/IκB Kinase and NF-κB Target Genes at the Pre-B to Immature B Cell Transition* , 2001, The Journal of Biological Chemistry.

[319]  Transactivation by the p65 Subunit of NF-κB in Response to Interleukin-1 (IL-1) Involves MyD88, IL-1 Receptor-Associated Kinase 1, TRAF-6, and Rac1 , 2001, Molecular and Cellular Biology.

[320]  T. Yoshikawa,et al.  The possible role of TNF-α and IL-2 in inducing tumor-associated metabolic alterations , 2004, Surgery Today.